Reduced Cish expression by siRNA knockdown in Natural Killer cells promotes anti-tumor effects against gastric cancer cell lines
Open Access
- 4 June 2025
- journal article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1004
Abstract
Improving immune cell functions in tumors remains a main challenge in cancer immunotherapy. NK are main innate effector cells with anti-tumor activity against various tumors. Consequently, NK cells are proper candidates for cancer immunotherapy, including gastric cancer. The IL-15 signaling pathway is negatively regulated by a protein called Cish encoded by the Cish gene. In the present study, we explored the knockdown of Cish and anti-tumor effects of NK cells. We knockdown Cish in human primary NK cells using siRNA, and the expression of Cish was evaluated by qRT-PCR. Gene expression analysis revealed that Cish expression increased after induction by IL-15 at various time point and conversely decreased after knockdown, approximately 44% and 41% reduction were observed at siRNA concentrations of 100 nmol/l at timepoint of 6h and 48h, respectively. Cish knockdown of human NK cells, showed enhanced the anti-tumor effects and induced apoptosis against a human gastric cancer cell lines called MKN-45 and AGS. Additionally, co-culture with MKN-45 and AGS cells showed increased secretion of IFN-γ and TNF-ɑ that could be related to higher cytotoxicity of knockdown Cish NK cells. Our results indicate that Cish knockdown human NK cells enhanced cytotoxicity and cytokine production when co-cultured with gastric cancer cell lines. siRNA-mediated Cish knockdown NK cells, might be a promising immunotherapeutic alternative in patients with gastric cancer.Keywords
This publication has 43 references indexed in Scilit:
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cellsNature Immunology, 2014
- Effect of tumor cells and tumor microenvironment on NK‐cell functionEuropean Journal of Immunology, 2014
- Suppression of cytokine signaling: The SOCS perspectiveCytokine & Growth Factor Reviews, 2013
- Targeting natural killer cells and natural killer T cells in cancerNature Reviews Immunology, 2012
- Adoptive immunotherapy for cancer: harnessing the T cell responseNature Reviews Immunology, 2012
- Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicityCancer Letters, 2008
- Negative regulation of cytokine signaling and inflammatory diseasesCurrent Opinion in Pharmacology, 2003
- A Perfect MismatchScience, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- SOCS Proteins: Negative Regulators of Cytokine SignalingStem Cells, 2001